Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 276-280

  Celebioglu, F ^a   Frisell, J ^a   Danielsson, R ^a   Bergkvist, L ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Non palpable; Sentinel node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXCISION; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PALPATION; PATIENT SAFETY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; REOPERATION; SENTINEL LYMPH NODE BIOPSY; SWEDEN;

EID: 33947689791     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.11.008     Document Type: Article

References (36)

1. Schrenk P., Rieger R., Shamiyeh A., and Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 3 (2000) 608-614
2. Burak W.E., Hollenbeck S.T., Zervos E.E., Hock K.L., Kemp L.C., and Young D.C. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183 1 (2002) 23-27
3. Schulze T., Mucke J., Markwardt J., Schlag P.M., and Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 2 (2006) 109-119
4. Haid A., Koberle-Wuhrer R., Knauer M., et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73 1 (2002) 31-36
5. Rietman J.S., Geertzen J.H., Hoekstra H.J., et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32 2 (2006) 148-152
6. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 546-553
7. Blanchard D.K., Donohue J.H., Reynolds C., and Grant C.S. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 5 (2003) 482-487 discussion 487-8
8. Peintinger F., Reitsamer R., Stranzl H., and Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89 4 (2003) 648-652
9. Ranaboldo C.J., Mitchel A., Royle G.T., Theaker G.M., and Taylor I. Axillary nodal status in women with screen-detected breast cancer. Eur J Surg Oncol 19 2 (1993) 130-133
10. Radford D.M., Cromack D.T., Troop B.R., Keller S.M., and Lopez M.J. Pathology and treatment of impalpable breast lesions. Am J Surg 164 5 (1992) 427-431 [discussion 431-2]
11. Walls J., Boggis C.R., Wilson M., et al. Treatment of the axilla in patients with screen-detected breast cancer. Br J Surg 80 4 (1993) 436-438
12. Cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 5 (1998) 645-651 [discussion 651-3]
13. Feldman S.M., Krag D.N., McNally R.K., Moor B.B., Weaver D.L., and Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 188 3 (1999) 248-254
14. Borgstein P.J., Pijpers R., Comans E.F., van Diest P.J., Boom R.P., and Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186 3 (1998) 275-283
15. Giuliano A.E., Jones R.C., Brennan M., and Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 6 (1997) 2345-2350
16. Miner T.J., Shriver C.D., Jaques D.P., Maniscalco-Theberge M.E., and Krag D.N. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 5 4 (1998) 315-321
17. Hill A.D., Tran K.N., Akhurst T., et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229 4 (1999) 528-535
18. Eary J.F., Mankoff D.A., Dunnwald L.K., et al. Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group. Radiology 213 2 (1999) 526-529
19. Rubio I.T., Korourian S., Cowan C., Krag D.N., Colvert M., and Klimberg V.S. Sentinel lymph node biopsy for staging breast cancer. Am J Surg 176 6 (1998) 532-537
20. Bergkvist L., Frisell J., Liljegren G., Celebioglu F., Damm S., and Thorn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88 12 (2001) 1644-1648
21. Celebioglu F., Sylvan M., Perbeck L., Bergkvist L., and Frisell J. Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery-A prospective study. Eur J Cancer 42 5 (2006) 617-620
22. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339 14 (1998) 941-946
23. Bergkvist L., and Frisell J. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 92 10 (2005) 1221-1224
24. Tafra L., Lannin D.R., Swanson M.S., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 1 (2001) 51-59
25. Kuehn T., Vogl F.D., Helms G., et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 30 3 (2004) 252-259
26. Zavagno G., Rubello D., Franchini Z., et al. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol 31 5 (2005) 479-484
27. Reitsamer R., Peintinger F., Rettenbacher L., Prokop E., and Sedlmayer F. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. World J Surg 27 12 (2003) 1291-1294
28. Zavagno G., Meggiolaro F., Rossi C.R., et al. Subareolar injection for sentinel lymph node location in breast cancer. Eur J Surg Oncol 28 7 (2002) 701-704
29. Newman L.A. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. J Am Coll Surg 199 5 (2004) 804-816
30. Litherland J.C. Should fine needle aspiration cytology in breast assessment be abandoned?. Clin Radiol 57 2 (2002) 81-84
31. Leifland K., Lagerstedt U., and Svane G. Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions. Acta Radiol 44 4 (2003) 387-391
32. Wells C.A., Perera R., White F.E., and Domizio P. Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. Breast 8 5 (1999) 261-266
33. van der Ent F.W., Kengen R.A., van der Pol H.A., and Hoofwijk A.G. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 25 1 (1999) 24-29
34. Haigh P.I., Hansen N.M., Qi K., and Giuliano A.E. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7 1 (2000) 21-27
35. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18 13 (2000) 2560-2566
36. Wong S.L., Edwards M.J., Chao C., et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 192 6 (2001) 684-689 discussion 689-91